- Home
- KZIA vs CJJD Comparison
KZIA vs CJJD Comparison
Compare KZIA & CJJD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- CJJD
- Stock Information
- Founded
- KZIA 1994
- CJJD 2003
- Country
- KZIA Australia
- CJJD China
- Employees
- KZIA N/A
- CJJD N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- CJJD Retail-Drug Stores and Proprietary Stores
- Sector
- KZIA Health Care
- CJJD Consumer Staples
- Exchange
- KZIA Nasdaq
- CJJD Nasdaq
- Market Cap
- KZIA 12.6M
- CJJD 12.2M
- IPO Year
- KZIA 1999
- CJJD N/A
- Fundamental
- Price
- KZIA $4.90
- CJJD $2.10
- Analyst Decision
- KZIA Strong Buy
- CJJD
- Analyst Count
- KZIA 1
- CJJD 0
- Target Price
- KZIA $20.00
- CJJD N/A
- AVG Volume (30 Days)
- KZIA 148.4K
- CJJD 14.0K
- Earning Date
- KZIA 11-19-2024
- CJJD 07-30-2024
- Dividend Yield
- KZIA N/A
- CJJD N/A
- EPS Growth
- KZIA N/A
- CJJD N/A
- EPS
- KZIA N/A
- CJJD N/A
- Revenue
- KZIA $382.00
- CJJD $154,541,077.00
- Revenue This Year
- KZIA $4,053,954.00
- CJJD N/A
- Revenue Next Year
- KZIA N/A
- CJJD N/A
- P/E Ratio
- KZIA N/A
- CJJD N/A
- Revenue Growth
- KZIA N/A
- CJJD 3.85
- 52 Week Low
- KZIA $1.90
- CJJD $1.34
- 52 Week High
- KZIA $15.80
- CJJD $5.00
- Technical
- Relative Strength Index (RSI)
- KZIA 50.25
- CJJD 50.95
- Support Level
- KZIA $5.21
- CJJD $2.07
- Resistance Level
- KZIA $6.88
- CJJD $2.24
- Average True Range (ATR)
- KZIA 0.76
- CJJD 0.21
- MACD
- KZIA -0.11
- CJJD -0.02
- Stochastic Oscillator
- KZIA 22.80
- CJJD 16.67
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.
About CJJD China Jo-Jo Drugstores Inc. (Cayman Islands)
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.